iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic
12 juil. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., July 12, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its...
iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting
10 juil. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., July 10, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it is...
iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award
18 mai 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its ProFound...
iCAD Reports Financial Results for First Quarter Ended March 31, 2023
15 mai 2023 16h01 HE
|
iCAD, Inc.
NASHUA, N.H., May 15, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial...
New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery
11 mai 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 11, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced compelling...
iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World’s Largest Breast Imaging Conference
03 mai 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 03, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will...
iCAD to Report First Quarter 2023 Financial Results on May 15, 2023
01 mai 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 01, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will...
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Boca Raton Regional Hospital
25 avr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 25, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its...
New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection without Increasing the Rate of Recalls and Reveals Critical Clues to Inform Clinical Decisions
20 avr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 20, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives
17 avr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 17, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board...